Heather Shapiro

Heather Shapiro's picture
Simon Lab

B.A., Neuroscience, Hamilton College (2005)

hmshapiro@ucdavis.edu

Shapiro_CV_031413.pdf
Lab Webpage: 
http://cabil.mindinstitute.org

   

 

 

I am a neuroscience graduate student in Dr. Tony Simon's Cognitive Analysis and Brain Imaging Lab at the MIND Institute.  I use brain imaging and experimental neurocognitive behavioral paradigms to examine neural correlates of cognitive control in children with Chromosome 22q11.2 Deletion Syndrome.

 

Selected Publications: 

 

Shapiro HM, Takarae Y, Harvey D, Cabaral M, and Simon TJ. A cross-sectional study of the development of volitional control of spatial attention in children with Chromosome 22q11.2 Deletion Syndrome. Journal of Neurodevelopmental Disorders. 4:5 (2012).

Halbig TD, Tse W, Frisina PG, Baker BR, Hollander E, Shapiro HM, Tagliati M, and Olanow CW. (2008). Subthalamic deep brain stimulation and impulse control in Parkinson's disease. European Journal of Neurology. 16, 493-497 (2009).

 

Manuscripts in Review/Prep:

Shapiro HM, Wong LM, and Simon TJ. Atypical development of response inhibition in children with Chromosome 22q11.2 Deletion Syndrome. In review.

Shapiro HM, Gothelf D, Harvey DJ, Takarae Y, Jalbrzikowski M, Weinberger R, Bearden CE, and Simon TJ. Atypical development of volitional attentional control is a robust phenomenon in children with Chromosome 22q11.2 Deletion Syndrome. In review.

Shapiro HM, Duan X, Supekar KS, Menon V, and Simon TJ. Atypical intrinsic brain networks and risk for psychopathology in children with Chromosome 22q11.2 Deletion Syndrome. In preparation.

Shapiro HM and Simon TJ. A cross-sectional study of the development of cognitive control in children with Chromosome 22q11.2 Deletion Syndrome, a population at high risk for schizophrenia. In preparation.

 

Invited Presentations:

Shapiro HM and Simon TJ. The development of cognitive control in children with chromosome 22q11.2 deletion syndrome. Velo-Cardio-Facial Syndrome Educational Foundation Annual International Scientific Meeting, Dublin, Ireland. 2013.

Shapiro HM. Difficulties in controlling cognitive responses when tasks get difficult. Chromosome 22q11.2 Deletion Syndrome Family Meeting, UC Davis MIND Institute, Sacramento, CA. 2013.

Shapiro HM, Quintero AI, Beaton EA, Angkustsiri K, Leckliter I, Enriquez J, and Simon TJ. Impaired cognitive control and its relationship to anxiety, adaptive functioning, and risk for psychopathology. International 22q11.2 Deletion Syndrome Meeting, Orlando, FL. 2012.

Shapiro HM. Cognitive Control Challenges: Difficulties in stopping the wrong response. Chromosome 22q11.2 Deletion Syndrome Family Meeting, UC Davis MIND Institute, Sacramento, CA. 2012.

Shapiro HM. The development of cognitive control in children with chromosome 22q11.2 deletion syndrome. UC Davis Annual Neuroscience Retreat. Monterey, CA. 2011.

Shapiro HM and Simon TJ. The development of cognitive control in children with chromosome 22q11.2 deletion syndrome. Velo-Cardio-Facial Syndrome Educational Foundation Annual International Scientific Meeting. New Brunswick, NJ. 2011.

Shapiro HM. Graduate student panel on what graduate school is really like, and what it takes to succeed. The Survival Skills & Ethics Program. Society for Neuroscience Annual Meeting, San Diego, CA. 2010.

Stoddard J and Shapiro HM. Cognitive, genetic, neural, and other factors affecting psychiatric disorders. Chromosome 22q11.2 Deletion Syndrome Family Meeting, UC Davis MIND Institute, Sacramento, CA. 2010.

Shapiro HM. The development of cognitive control in children with chromosome 22q11.2 deletion syndrome. MIND Institute Research Seminar Series, UC Davis, Sacramento, CA. 2010.

Shapiro HM, Takarae Y, Harvey D, Angkustsiri K, and Simon TJ. Attentional control throughout development in children with chromosome 22q11.2 deletion syndrome (22q11.2DS)/VCFS. Velo-Cardio-Facial Syndrome Educational Foundation Annual International Scientific Meeting, Salt Lake City, UT. 2010.

 

Abstracts:

Cruz J, Wong LM, Angkustsiri K, Shapiro HM, Fox N, Pine D, Perez-Edgar K, and Simon TJ. Examining attention bias towards threat to understand cognition and anxiety interactions in children with chromosome 22q11.2 deletion syndrome. Velo-Cardio-Facial Syndrome Educational Foundation Annual International Scientific Meeting, Dublin, Ireland. 2013.

Simon TJ, Angkustsiri K, Quintero A, Cruz J, Wong LM, Beaton EA, Leckliter I, Enriquez J, and Shapiro HM. Cognitive function is related to anxiety and adaptive function in children with chromosome 22q11.2 deletion syndrome. Velo-Cardio-Facial Syndrome Educational Foundation Annual International Scientific Meeting, Toronto, Canada. 2012.

Shapiro HM, Duan X, Supekar KS, Menon V, and Simon TJ. Atypical intrinsic brain networks and risk for psychopathology in children with chromosome 22q11.2 deletion syndrome. Society of Biological Psychiatry Annual Meeting, Philadelphia, PA. 2012.

Simon TJ, Shapiro HM, Wong LM, Beaton EA, Cabaral M, and Cruz J. Reduced resolution of spatial and temporal processing in children with chromosome 22q11.2 deletion syndrome and implications for functioning. International 22q11.2 Deletion Syndrome Meeting, Orlando, FL. 2012.

Simon TJ, Angkustsiri K, Beaton EA, Quintero AI, and Shapiro HM. Cognitive control is related to anxiety and adaptive function in children with chromosome 22q11.2 deletion syndrome: a population with ultra-high schizophrenia risk. Society of Biological Psychiatry Annual Meeting, Philadelphia, PA. 2012.

Shapiro HM, Harvey D, and Simon TJ. The development of cognitive control in children with chromosome 22q11.2 deletion syndrome. Conference on the Determinants of Executive Function & Dysfunction, Boulder, CO. 2012.

Shapiro HM, Harvey D, and Simon TJ. The development of cognitive control in children with chromosome 22q11.2 deletion syndrome. Society for Neuroscience Annual Meeting, Washington, DC. 2011.

Shapiro HM and Simon TJ. The development of response inhibition in children with chromosome 22q11.2 deletion syndrome. Society of Biological Psychiatry Annual Meeting, San Francisco, CA. 2011.

Stoddard JJ, Shapiro HM, Cruz J, and Simon TJ. Impairment in reactive control in youth with chromosome 22q11.2 deletion syndrome. Society of Biological Psychiatry Annual Meeting, San Francisco, CA. 2011.

Shapiro HM, Bishop CW, Lee A, and Simon TJ. Structural abnormalities in the basal ganglia in children with chromosome 22q11.2 deletion syndrome. Society for Neuroscience Annual Meeting, San Diego, CA. 2010.

Srivastava S, Shapiro HM, McLennan Y, Marcelino L, Godwin C, Tassone F, Rivera S, and Simon TJ. Evidence for neural connectivity anomalies in adult female FMR1 premutation carriers without evident degenerative neurocognitive symptoms. Society of Cognitive Neuroscience Annual Meeting, Montreal, Canada. 2010.

Goodrich-Hunsaker NJ, Hasimoto RI, Hatt NV, Shapiro HM, Marcelino L, McLennan Y, Godwin C, Tassone F, Rivera S, and Simon TJ. Magnitude comparison in females with the Fragile X premutation. Society of Cognitive Neuroscience Annual Meeting, Montreal, Canada. 2010.

Rivera SM, Hashimoto R, Hatt NV, Shapiro HM, and Simon TJ. Evidence for a dose-sensitive response to FMR1 gene expression in the fronto-parietal cortex. Society for Neuroscience Annual Meeting, Chicago, IL. 2009.

Shapiro HM, Tukarae Y, Beaton EA, Johnson J, and Simon TJ. Selective attentional impairments in cihlidren with chromosome 22q11.2 deletion syndrome. Society of Cognitive Neuroscience Annual Meeting, San Francisco, CA. 2009.

Shapiro HM, Zhang H, Amaral DG, Lee A, and Simon TJ. Possible key role for the pulvinar nucleus of the thalamus in cognitive impairment in children with chromosome 22q11.2 deletion syndrome. Society of Biological Psychiatry Annual Meeting, Washington DC. 2008.

Shapiro HM, Weisz D, and Raghavan P. Role of task specificity and weight perception for internal representation of object weight. Society for Neuroscience Annual Meeting, San Diego, CA. 2007.

Shapiro HM, Newmark RE, Haznedar M, Byne W, Goldstein KE, Hazlett EA, and Buchsbaum MS. Activation and volume differences in the basal ganglia in adolescent patients with psychosis. Society of Biological Psychiatry Annual Meeting, San Diego, CA. 2007.